Effect of subhypnotic doses of dexmedetomidine on antitumor immunity in mice

Immunopharmacology and Immunotoxicology

Volumn 27, Issue 3, 2005, Pages 357-369

  Inada, Takefumi ^a   Shirane, Atsuko ^a   Hamano, Nobuyuki ^a   Yamada, Makiko ^a   Kambara, Tomoko ^a   Shingu, Koh ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Antitumor immunity; Cytotoxic T lymphocytes; Dexmedetomidine

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; DEXMEDETOMIDINE; INTERLEUKIN 2; THIOGLYCOLIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DOSE RESPONSE; INTENSIVE CARE; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEDATION; TH1 CELL; TH2 CELL; TUMOR CELL LINE; TUMOR GROWTH; TUMOR IMMUNITY;

ANIMALS; DEXMEDETOMIDINE; HYPNOTICS AND SEDATIVES; IMMUNITY; INTERLEUKIN-12; MACROPHAGES, PERITONEAL; MICE; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; SPLEEN; T-LYMPHOCYTES, CYTOTOXIC; TH1 CELLS; TH2 CELLS; THIOGLYCOLATES;

EID: 26444494992     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.1080/08923970500240883     Document Type: Article

References (23)

1. Bhana, N.; Goa, K.L.; McClellan, K.J. Dexmedetomidine. Drugs 2000, 59, 263-270.
2. Martin, E.; Ramsay, G.; Mantz, J.; Sun-Ping, S.T. The role of the α2-adrenoceptor agonist dexmedetomidine in postsurgical sedation in the intensive care unit. J. Intensive Care Med. 2003, 18, 29-41.
3. Talke, P.; Chen, R.; Thomas, B.; Aggarwall, A.; Gottlieb, A.; Thorborg, P.; Heard, S.; Cheung, A.; Son, S.L.; Kallio, A. The hemodynamic and adrenergic effects of perioperative dexmedetomidine infusion after vascular surgery. Anesth. Analg. 2000, 90, 834-839.
4. Sredni, B.; Tichler, T.; Shani, A.; Catane, R.; Kaufman, B.; Strassmann, G.; Albeck, M.; Kalechman, Y. Predominance of TH1 response in tumor-bearing mice and cancer patients treated with AS101. J. Natl. Cancer Inst. 1996, 88, 1276-1284.
5. Nishimura, T.; Iwakabe, K.; Sekimoto, M.; Ohmi, Y.; Yahata, T.; Nakui, M.; Sato, T.; Habu, S.; Tashiro, H.; Sato, M.; Ohta, A. Distinct role of antigen-specific T helper type 1 (Th1) and Th2 cells in tumor eradication in vivo. J. Exp. Med. 1999, 190, 617-627.
6. Nakamori, M.; Iwahashi, M.; Nakamura, M.; Ueda, K.; Zhang, X.; Yamaue, H. Intensification of antitumor effect by T helper 1-dominant adoptive immunogene therapy for advanced orthotopic colon cancer. Clin. Cancer Res. 2003, 9, 2357-2365.
7. Rook, G.; Balkwill, F. Cell-mediated immune reactions. In Immunology; Roitt, I., Brostoff, J., Male, D., Eds.; Mosby: London, 1998; 121-138.
8. Irwin, M. Stress-induced immune suppression: role of brain corticotropin releasing hormone and autonomic nervous system mechanisms. Adv. Neuroimmunol. 1994, 4, 29-47.
9. Elenkov, I.J.; Papanicolaou, D.A.; Wilder, R.L.; Chrousos, G.P. Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications. Proc. Assoc. Am. Physicians 1996, 108, 374-381.
10. Szelényi, J.; Kiss, J.P.; Vizi, E.S. Differential involvement of sympathetic nervous system and immune system in the modulation of TNF-α production by α2- and β-adrenoceptors in mice. J. Neuroimmunol. 2000, 103, 34-40.
11. Spengler, R.N.; Allen, R.M.; Remick, D.G.; Strieter, R.M.; Kunkel, S.L. Stimulation of α-adrenergic receptor augments the production of macrophage-derived tumor necrosis factor. J. Immunol. 1990, 145, 1430-1434.
12. Weatherby, K.E.; Zwilling, B.S.; Lafuse, W.P. Resistance of macrophages to mycobacterium avium is induced by α2-adrenergic stimulation. Infect. Immun. 2003, 71, 22-29.
13. Kang, B.Y.; Lee, S.W.; Kim, T.S. Stimulation of interleukin-12 production in mouse macrophages via activation of p38 mitogen-activated protein kinase by α2-adrenoceptor agonists. Eur. J. Pharmacol. 2003, 467, 223-231.
14. Davies, M.F.; Tsui, J.; Flannery, J.A.; Li, X.; DeLorey, T.M.; Hoffman, B.B. Activation of α2 adrenergic receptors suppresses fear conditioning: expression of c-Fos and phosphorylated CREB in mouse amygdala. Neuropsychopharmacology 2004, 29, 229-239.
15. Ozdogan, U.K.; Lahdesmaki, J.; Hakala, K.; Scheinin, M. The involvement of α2A-adrenoceptors in morphine analgesia, tolerance and withdrawal in mice. Eur. J. Pharmacol. 2004, 497, 161-171.
16. Picker, L.J.; Singh, M.K.; Zdraveski, Z.; Treer, J.R.; Waldrop, S.L.; Bergstresser, P.R.; Maino, V.C. Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry. Blood 1995, 86, 1408-1419.
17. Piriou, L.; Chilmonczyk, S.; Genetet, N.; Albina, E. Design of a flow cytometric assay for the determination of natural killer and cytotoxic T-lymphocyte activity in human and in different animal species. Cytometry 2000, 41, 289-297.
18. Mahajan, S.D.; Aalinkeel, R.; Schwartz, S.A.; Chawda, R.P.; Nair, M.P. Effector cell mediated cytotoxicity measured by intracellular granzyme B release in HIV infected subjects. Biol. Proced. Online 2003, 5, 182-188.
19. Xu, F.; Ye, Y.J.; Wang, S. In vitro antitumor immune response induced by fusion of dendritic cells and colon cancer cells. World J. Gastroenterol. 2004, 10, 1162-1166.
20. Taylor, G.G.; Potter, A.J.; Rabinovitch, P.S. Splenocyte glutathione and CD3-mediated cell proliferation are reduced in mice fed a protein-deficient diet. J. Nutr. 1997, 127, 44-50.
21. Robinson, L.E.; Clandinin, M.T.; Field, C.J. R3230AC rat mammary tumor and dietary long-chain (n-3) fatty acids change immune cell composition and function during mitogen activation. J. Nutr. 2001, 131, 2021-2027.
22. Kribben, A.; Herget-Rosenthal, S.; Lange, B.; Erdbrugger, W.; Philipp, T.; Michel, M.C. α2-adrenoceptors in opossum kidney cells couple to stimulation of mitogen-activated protein kinase independently of adenylyl cyclase inhibition. Naunyn-Schmiedeberg's Arch. Pharmacol. 1997, 356, 225-232.
23. Olli-Lähdesmäki, T.; Tiger, M.; Vainio, M.; Scheinin, M.; Kallio, J. Ligand-induced α2-adrenoceptor endocytosis: relationship to Gi protein activation. Biochem. Biophys. Res. Commun. 2004, 13 (321), 226-233.